This randomized controlled trial compares hydrophilic methacrylate gel versus beta-sitosterol ointment for early cesarean section scar healing. Adult women who underwent cesarean delivery were randomly assigned to receive either hydrophilic methacrylate gel (n=58) or beta-sitosterol ointment (n=59). Scar outcomes were assessed by trained nurses blinded to treatment allocation and by patients at two time points approximately 12 days apart. The primary outcome was scar redness measured by the Vancouver Scar Scale. Secondary outcomes included pigmentation, pliability, scar height, and patient-reported measures including pain, itching, satisfaction, and treatment recommendation.
Wound healing following cesarean delivery is a complex biological process influenced by mechanical stress, inflammatory response, tissue perfusion, and patient-related factors. This prospective randomized single-blinded controlled trial enrolled adult women who underwent elective or emergency cesarean section at a tertiary care maternity hospital in Qatar. Exclusion criteria included surgical site infection at baseline, dermatological conditions affecting wound healing, hypersensitivity to study products, systemic inflammatory disease, or inability to attend follow-up. Participants were randomly assigned to receive either hydrophilic methacrylate gel (n=58) or beta-sitosterol ointment (n=59) applied to the cesarean incision site starting in the early postoperative period. Outcome assessments were performed by trained nurses blinded to treatment allocation and by patients at two time points approximately 12 days apart. Nurse-assessed outcomes used the Vancouver Scar Scale (vascularity/redness, pigmentation, pliability, scar height). Patient-reported outcomes used the Patient and Observer Scar Assessment Scale (pain, itching, color, thickness, stiffness, irregularity, satisfaction, perceived effectiveness, ease of application, likelihood of recommending treatment).
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Enrollment
117
Topical ointment containing beta-sitosterol applied to cesarean section incision site
Hydrophilic methacrylate-based hydrogel applied to cesarean section incision site
Al Wakra Hospital
Doha, Qatar
Scar Redness (Vascularity) Assessed by Vancouver Scar Scale (VSS)
Measured using the Vancouver Scar Scale (VSS) - Vascularity subscale (score range: 0-3, where higher scores indicate worse redness), assessed by trained nurses blinded to treatment allocation.
Time frame: Assessed at two time points: Day 5 postpartum and Day 12 postpartum
Scar Pigmentation Assessed by Vancouver Scar Scale (VSS)
Measured using the Vancouver Scar Scale (VSS) - Pigmentation subscale (score range: 0-3, where higher scores indicate worse pigmentation).
Time frame: Day 5 postpartum and Day 12 postpartum
Scar Height Assessed by Vancouver Scar Scale (VSS)
Measured using the Vancouver Scar Scale (VSS) - Height subscale (score range: 0-3, where higher scores indicate greater scar thickness).
Time frame: Day 5 postpartum and Day 12 postpartum
Patient-Reported Pain Assessed by Patient and Observer Scar Assessment Scale (POSAS)
Measured using the Patient and Observer Scar Assessment Scale (POSAS) - Pain item (score range: 1-10, where higher scores indicate worse pain).
Time frame: Day 5 postpartum and Day 12 postpartum
Patient-Reported Itching Assessed by Patient and Observer Scar Assessment Scale (POSAS)
Measured using the Patient and Observer Scar Assessment Scale (POSAS) - Itching item (score range: 1-10, where higher scores indicate worse itching).
Time frame: Day 12 postpartum
Patient Satisfaction (Patient-Reported Outcome)
Patient-reported overall satisfaction with treatment (categorized as satisfied/very satisfied vs not satisfied).
Time frame: Day 12 postpartum
Treatment Effectiveness Perception (Patient-Reported Outcome)
Patient-reported perceived effectiveness of treatment (categorized as effective/very effective vs not effective).
Time frame: Day 12 postpartum
Likelihood of Treatment Recommendation (Patient-Reported Outcome)
Patient-reported likelihood of recommending the treatment to others (ordinal scale; higher values indicate greater likelihood).
Time frame: Day 12 postpartum
Ease of Application (Patient-Reported Outcome)
Patient-reported ease of applying the topical treatment (ordinal scale; higher values indicate easier application).
Time frame: Day 12 postpartum
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.